Tissue Inhibitor of Metalloproteinases-2 Mediates Kidney Injury during Sepsis

Nephron. 2020;144(12):644-649. doi: 10.1159/000511165. Epub 2020 Oct 22.

Abstract

Introduction: Urinary tissue inhibitor of metalloproteinases (TIMP)-2 has been identified as a predictive marker for acute kidney injury (AKI), including sepsis-associated AKI (S-AKI). Whether TIMP-2 might be causally related to AKI and hence represent a viable drug target is unclear.

Objective: The aim of this study was to evaluate whether suppression of TIMP-2 attenuates S-AKI.

Methods: Balb/c mice were randomized to sham or cecal ligation and puncture surgery and treated with or without a TIMP-2-neutralizing antibody. Animals were followed for 48 h and then sacrificed for analysis of TIMP-2 expression, cell cycle, and histology.

Results: Anti-TIMP-2 resulted in decreased lumen TIMP-2 expression which markedly increased cell cycle progression and attenuated epithelial cell injury by histology.

Conclusions: TIMP-2 mediates S-AKI and appears to be a viable drug target.

Keywords: Kidney injury; Secretory TIMP-2; Sepsis.

Publication types

  • Review

MeSH terms

  • Acute Kidney Injury / complications
  • Acute Kidney Injury / pathology
  • Acute Kidney Injury / physiopathology*
  • Aged
  • Animals
  • Cell Cycle
  • Epithelial Cells / pathology
  • Flow Cytometry
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Sepsis / complications*
  • Sepsis / pathology
  • Tissue Inhibitor of Metalloproteinase-2 / physiology*

Substances

  • TIMP2 protein, human
  • Tissue Inhibitor of Metalloproteinase-2